SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891092-03-000411
Filing Date
2003-03-13
Accepted
2003-03-13 13:11:54
Documents
9
Period of Report
2003-03-12
Items
Item 2: Acquisition or disposition of assets
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e14423_8k.txt 8-K 8596
3 EXHIBIT 2.1 e14423ex2_1.txt EX-2.1 34677
4 EXHIBIT 2.2 e14423ex2_2.txt EX-2.2 40531
5 EXHIBIT 10.1 e14423ex10_1.txt EX-10.1 15420
6 EXHIBIT 10.2 e14423ex10_2.txt EX-10.2 14651
7 EXHIBIT 10.3 e14423ex10_3.txt EX-10.3 127011
8 EXHIBIT 10.4 e14423ex10_4.txt EX-10.4 172659
9 EXHIBIT 10.5 e14423ex10_5.txt EX-10.5 71061
10 EXHIBIT 10.6 e14423ex10_6.txt EX-10.6 69625
  Complete submission text file 0000891092-03-000411.txt   556839
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-13441 | Film No.: 03602041
SIC: 2836 Biological Products, (No Diagnostic Substances)